Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04683770
Status:
UNKNOWN
Last Update Posted:
2020-12-24
First Post:
2020-12-19
Brief Title:
Prognostic Value of Biomarkers in HR HER2 - Advanced Breast Cancer
Sponsor:
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
The object of this study is to detect the gene mutation of tumor tissue or peripheral blood circulation tumor DNA of tumor patients 10ml of tissue or fresh peripheral blood should be collected as the test sample and stored at room temperature On the same day it was sent to the cell and molecular diagnosis center of our hospital for DNA isolation and extraction second-generation sequencing and detection of related biomarkers The clinical total exome sequencing 4813 gene kit developed by Illumina company was used for embryo line detection and the system detection project used the system detection chip designed by the laboratory
Enrollment Count:
200
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 71291 |
Who Masked List: